Literature DB >> 33886026

Polymorphism of TUSC7 associated with gastric cancer susceptibility and binding with miR-133a-3p: a population-based case-control study.

Qian Yang1,2, Chunhua Song1,2, Peng Wang1,2, Hua Ye1,2, Liping Dai2,3, Jianying Zhang1,2,3, Kaijuan Wang4,5.   

Abstract

BACKGROUND: Previous studies have demonstrated that gene polymorphism is associated with cancer susceptibility. Most of these genes are involved in neoplastic processes. Previous studies demonstrated that tumor-suppressor candidate 7 (TUSC7) was a tumor-suppressor gene in various tumors. This study aims to explore the association between lncRNA TUSC7 polymorphism and gastric cancer susceptibility and the potential function.
METHODS: The tagging SNPs of TUSC7 were genotyped with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in a Chinese Han population-based case-control study. The relative expression level of TUSC7 in plasma was conducted by quantitative real-time PCR (qRT-PCR). The gene-environment interaction was analyzed by multifactor dimensionality reduction (MDR). The dual luciferase reporter assay was used to examine whether SNP rs12494960 of TUSC7 allele variation affected the binding of lncRNA-TUSC7 and miRNAs miR-133a-3p.
RESULTS: Three tagging SNPs (rs12494960, rs1518338, rs2867837) of TUSC7 were selected to validate in population. The unconditional multiple logistic regression showed that individuals with genotype AA (OR: 1.79, 95% CI: 1.16, 2.70) of rs12494960 and GG (OR: 2.24, 95% CI: 1.12, 4.46) of rs2867837 in TUSC7 had increased risk of GC susceptibility. The qRT-PCR showed that CA and AA genotype of rs12494960 in TUSC7 had significantly lower relative expression level in plasma, compared with CC genotype. The dual luciferase reporter assay showed that TUSC7 and miR-133a-3p had interaction.
CONCLUSION: The mutant genotype of rs12494960 could increase the susceptibility of gastric cancer and might affect the corresponding mRNA expression of lncRNA TUSC7 in plasma.

Entities:  

Keywords:  Biomarker; Cancer susceptibility; Gastric cancer; Long non-coding RNA; SNPs

Year:  2021        PMID: 33886026     DOI: 10.1007/s10147-021-01924-w

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  2 in total

1.  MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ.

Authors:  Yuan Huang; Yaoshi Wu; Jiahong Dong; Dongdong Han; Shiwei Yang; Lin Jiang
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

2.  TUSC7 acts as a tumor suppressor in colorectal cancer.

Authors:  Weidan Ren; Shuo Chen; Guiwei Liu; Xuesong Wang; Haopeng Ye; Yanguo Xi
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

  2 in total
  1 in total

1.  Effect of Combining Early Chemotherapy with Zhipu Liujunzi Decoction under the Concept of Strengthening and Consolidating Body Resistance for Gastric Cancer Patients and Nursing Strategy.

Authors:  Min Wang; Shujuan Wang; Qiang Su; Tian Ma
Journal:  Contrast Media Mol Imaging       Date:  2021-11-30       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.